This inventor holds 17 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Cancer Treatment. Top assignees: Kura Oncology, Inc., Pfizer Corporation, Kura Oncolofy, Inc.. Active years: 2009-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- East Greenwich, RI (US) (2009 - 2015)
- Acton, MA (US) (2017 - 2023)
Company Filing History:
13 out of 34 
2 out of 4,489 
1 out of 1 
Years Active: 2009-2023
Areas of Expertise:
Title: Antonio Gualberto: Innovator in Cancer Therapy
Introduction
Antonio Gualberto is a prominent inventor based in Acton, MA (US), known for his significant contributions to cancer therapy. With a total of 17 patents to his name, Gualberto has focused on developing innovative methods to treat various forms of cancer, particularly through the use of farnesyltransferase inhibitors.
Latest Patents
Gualberto's latest patents include groundbreaking methods of treating cancer with farnesyltransferase inhibitors. One patent specifically addresses the treatment of peripheral T-cell lymphoma (PTCL) by determining whether a subject is likely to respond to farnesyltransferase inhibitor (FTI) treatment based on gene expression characteristics. Another patent outlines methods for treating cancer in subjects exhibiting clinical signs of bone marrow homing of myeloid cells, including neutropenia. This method also involves assessing the likelihood of responsiveness to FTI treatment based on hematological characteristics.
Career Highlights
Throughout his career, Gualberto has worked with notable companies in the pharmaceutical industry, including Kura Oncology, Inc. and Pfizer Corporation. His work has significantly advanced the understanding and treatment of cancer, making him a key figure in the field of oncology.
Collaborations
Gualberto has collaborated with esteemed colleagues such as Catherine Rose Scholz and Carrie L Melvin, contributing to the development of innovative cancer therapies.
Conclusion
Antonio Gualberto's work in cancer therapy exemplifies the impact of innovation in medicine. His patents and collaborations continue to pave the way for advancements in cancer treatment, showcasing his dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile